ReShape Lifesciences Inc (RSLS): Can retest the 52-week high of $30 at th...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

ReShape Lifesciences Inc (RSLS)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	21
Posts	1284
Boards Moderated	0
Alias Born	02/12/2021

Re: None

Tuesday, 04/01/2025 7:14:32 PM

Tuesday, April 01, 2025 7:14:32 PM

Can retest the 52-week high of $30 at this rate

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RSLS News

Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 10:16:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 08:44:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2025 09:24:22 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2025 07:53:13 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/12/2025 08:10:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2025 01:21:17 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/02/2025 12:04:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2025 09:23:32 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/20/2025 09:21:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2025 09:29:47 PM
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow • Business Wire • 08/14/2025 11:18:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:20:20 PM
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND • Business Wire • 08/13/2025 03:50:00 PM
Vyome Announces New Board of Directors with Deep MIT and AI Ties • Business Wire • 08/12/2025 01:48:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:05:51 PM
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics • Business Wire • 08/07/2025 09:01:00 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/30/2025 05:28:18 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/25/2025 08:08:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2025 08:06:57 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 07/24/2025 09:24:19 PM

More RSLS News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow